ClinConnect ClinConnect Logo
Search / Trial NCT05525299

Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors

Launched by THE UNIVERSITY OF HONG KONG · Aug 30, 2022

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how a special program, called a reminiscence-based life review, can help older cancer survivors cope with feelings of existential suffering, which includes questions about the meaning of life and emotional distress. The program involves six sessions where participants will talk about their life experiences and memories. It aims to provide psychological support and improve cognitive function, social support, and overall well-being for those who are 65 years or older and have mild cognitive impairment after cancer treatment.

To participate, individuals must be at least 65 years old, diagnosed with early-stage non-metastatic cancer, and have completed their primary cancer treatment within the past 6 months to 5 years. Participants will be randomly assigned to either receive the reminiscence program or standard care and will be assessed at the beginning, after the sessions, and again six weeks later to see how the program affected their feelings and cognitive function. This trial is currently recruiting participants, and feedback will be collected from those in the intervention group to understand their experiences better.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged ≥ 65 years
  • Diagnosed with stage I-III non-metastatic cancer
  • Completed primary treatment with curative intent (surgery, chemotherapy, and/or radiation therapy) 6 months to 5 years prior to baseline assessments with no recurrence or occurrence of additional cancers
  • identified as mild cognitive impairment by the HK-MoCA 5-Min Protocol cognitive assessment (≤ 7th age and education corrected percentile cutoff score)
  • Exclusion Criteria:
  • Inadequate written and verbal Cantonese and/or English comprehension for study activities
  • Diagnosed with dementia

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Mu-Hsing Ho, PhD

Principal Investigator

The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials